Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page
B
B
Department of Transplantation, Necker Hospital, Paris, France.
Morin
M P
MP
Mamzer
M F
MF
Thervet
E
E
Legendre
C
C
D003586:Cytomegalovirus Infections / Q000150:complications; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D007970:Leukopenia / Q000188:drug therapy* / Q000209:etiology*; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor